← SynDRA
ANISINDIONE
SynDRA canonical compound SYN0001532 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | GGCX |
|---|
| Mechanism of action | vitamin K antagonist |
|---|
| Indication | deep vein thrombosis (DVT) |
|---|
| Disease area | hematology |
|---|
All known targets
Mechanisms of action (all sources)
- GGCX INHIBITOR
- Vitamin K-dependent gamma-carboxylase inhibitor
- vitamin K antagonist
- F2 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR1
- ACHE
- MAPK1
- NPY2R
- NPY1R
- NPC1
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPT
- MAPK3
- MAPK14
- MAOA
- HDAC6
- LCK
- KCNH2
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH2
- HRH1
- HPGD
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- TP53
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SMN1
- SLCO1B3
- SLCO1B1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CASP3
- CP2CJ
- ESRRA
- HDAC9
- SENP6
- SENP7
- SENP8
- SMN
Cross-references
Synonyms
- MIRADON
- andion
- miradon
- unidone
- Anisindiona
- NSC-759629
- Miradon
- Anisindionum
- Unidone
- Anisin indandione
- SPE 2792
- Anisindiona [INN-Spanish]
- Anisindione (INN)
- Anisindione [INN:BAN]
- Anisindionum [INN-Latin]
- Miradon (TN)
- 2-(4-Methoxy-phenyl)-indan-1,3-dione
- 2-(4-Methoxyphenyl)indan-1,3-dione
- 2-(4-methoxyphenyl)indene-1,3-dione
- 2-(p-Methoxyphenyl)-1,3-indandione
- 2-(p-Methoxyphenyl)indane-1,3-dione
- 2-[4-(methyloxy)phenyl]-1H-indene-1,3(2H)-dione
- 2-p-Anisyl-1,3-indandione
- 2-para-Anisyl-1,3-indandione
- S747T1ERAJ
- NSC 759629
- 1,3-Indandione, 2-(p-methoxyphenyl)-
- 1,3-Indanedione, 2-(4-methoxyphenyl)-
- DTXCID102611
- CHEBI:133809
- RefChem:54219
- MFCD00176194
- MLS000554135
- NCGC00094969-01
- SMR000146452
- ANISINDIONE [INN]
- CAS-117-37-3
- HSDB 3205
Look up ANISINDIONE in the interactive SynDRA portal →